Patrick O’Brien
General Counsel
Arrowhead Pharmaceuticals, Inc. (ARWR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Operating Officer and General Counsel | $605,259 | $3,933,570 |
| 2023 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Operating Officer and General Counsel | $568,422 | $3,310,337 |
| 2022 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Operating Officer and General Counsel | $500,466 | $4,727,863 |
| 2021 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Operating Officer and General Counsel | $479,762 | $5,336,926 |
| 2020 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Operating Officer and General Counsel | $459,100 | $5,123,502 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.